DistantNews
Support us
Hanmi Group promotes executives for contributions to drug development and global exports
🇰🇷 South Korea /Economy & Trade

Hanmi Group promotes executives for contributions to drug development and global exports

From Chosun Ilbo · () Korean

Translated from Korean, summarized and contextualized by DistantNews.

At a glance

News Official statement New plan
  • Hanmi Group promoted six executives in its first regular mid-year reshuffle since establishing a professional management system.
  • Promotions recognized achievements in key growth areas including obesity/metabolic disease drug development, global technology exports, R&D, and medical devices.
  • The promotions included three executives at the holding company Hanmi Science and three at the operating company Hanmi Pharmaceutical.

Hanmi Group has announced its first mid-year executive promotions under its new professional management system, elevating six individuals who demonstrated significant contributions to the company's growth.

The promotions span critical areas such as the development of new drugs for obesity and metabolic diseases, successful global technology exports, robust research and development (R&D) initiatives, and advancements in medical devices. These key sectors are central to Hanmi's strategic growth objectives.

Of the six promoted executives, three are from the group's holding company, Hanmi Science, and three are from the operating entity, Hanmi Pharmaceutical. The reshuffle reflects the company's commitment to recognizing and rewarding performance in its core business areas.

DistantNews Editorial

Originally published by Chosun Ilbo in Korean. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.

More Stories

From Our Blog